Contact Center Solutions Industry News

TMCNet:  Hot Stock: Keryx Biopharmaceuticals, Shares Gain 43.4% (KERX)

[January 28, 2013]

Hot Stock: Keryx Biopharmaceuticals, Shares Gain 43.4% (KERX)

Jan 28, 2013 (SmarTrend(R) Spotlight via COMTEX) -- Keryx Biopharmaceuticals (NASDAQ:KERX) is one of today's best performing low-priced stocks, up 43.4% to $4.92 on 8.0x average daily volume. Thus far today, Keryx Biopharmaceuticals has traded 14.1 million shares, vs. average volume of 1.8 million shares per day. The stock has outperformed the Dow (43.4% to the Dow's -0.1%) and outperformed the S&P 500 (43.4% to the S&P's -0.2%) during today's trading.

Keryx Biopharmaceuticals (NASDAQ:KERX) is currently priced 6.0% above its average consensus analyst price target of $4.62. Keryx Biopharmaceuticals shares have support at the 50-day moving average (MA) of $2.86 and additional support at the 200-day MA of $2.24.

In the past 52 weeks, shares of Keryx Biopharmaceuticals have traded between a low of $1.28 and a high of $5.55 and are now at $4.92, which is 284% above that low price. Over the past week, the 200-day moving average (MA) has gone up 1.8% while the 50-day MA has advanced 3.2%.

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Keryx is developing KRX-101 (sulodexide), a novel first-in-class oral heparinold compound for the treatment of diabetic nephropathy.

SmarTrend recommended that subscribers consider buying shares of Keryx Biopharmaceuticals on April 24th, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $1.83. Since that recommendation, shares of Keryx Biopharmaceuticals have risen 87.4%. We continue to monitor KERX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Write to Chip Brian at cbrian@mysmartrend.com --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To Contact Center Solutions Homepage's Homepage ]



Related Contact Center Solutions Articles

FOLLOW US

Contact Center Solutions Glossary of Terms

Featured Whitepaper

    Microsoft® Lync® in the Contact Center: Integrating with Customer Interaction Center™ to Provide a Barrier‐free Customer Experience To implement contact center functionality, organizations using Microsoft Lync Server 2010 can follow the unified communications blueprint of open standards interoperability and integrate to a contact center solution of their choice. Customer Interaction Center (CIC) from Interactive Intelligence is a proven best of breed contact center solution that merits consideration ...

Featured Success Story

    Contact Center Solutions Featured Success Story
    Interactive Intelligence all-in-one IP communications software suite integrated with Microsoft Lync helps Bentley save $200,000 annually.

Featured Product Demo

    Contact Center Solutions Interaction Analyzer™
    Interaction Analyzer™
    Real-time word and phrase spotting. Alerting. Analytics. Scoring. Coaching. Watch how Interaction Analyzer turns every moment, of every past and present call, into data that lets you deliver an exceptional customer experience.

Featured Resources